1 January 2012PatentsArchana Shanker

A step into the unknown: India's first compulsory license

The licence was granted to Natco Pharma, a generic drug company, for sorafenib tosylate, a life-extending drug developed, patented and launched by Bayer Corporation. This drug is sold under the trade name of Nexavar and is used for the treatment of advanced-stage kidney and liver cancer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Influential Women in IP

The real impact of judgments

1 December 2020 Justice Prabha Sridevan has left her mark on the Indian IP industry, first as a judge of the Madras High Court, and then as chair of the Intellectual Property Appellate Board. Here, she tells WIPR about two cases that she will always remember.

India e-commerce: Liability for platforms is coming at last

24 September 2019 India’s booming e-commerce industry has remained largely immune to the cries of rights owners, but not for much longer, explains Pravin Anand, Jaya Negi and Souradeep Mukhopadhyay.

The UPC, a tiny LED, and the eight-country injunction

Axinn adds litigator with ‘cutting-edge tech’ acumen

Netlist counsel: How we beat Samsung in computer chip clash, again

Cleary Gottlieb brings in five-partner team from Latham & Watkins

HSF expands Europe tech litigation team

Acting USPTO director enacts new PTAB policy with Motorola decision

Nokia and Amazon resolve global dispute over Prime Video and streaming devices

Blank Rome adds ‘dedicated’ patent litigator in Texas

A step into the unknown: India's first compulsory license

More on this story

Editor's picks

Editor's picks

More articles